We’re passionate about improving the quality of life for people with solid cancer
Cartherics aims for a better quality of life for cancer patients with its CAR-iNK technologies aimed at enabling better, lower cost and more accessible treatment for patients.
Immunotherapy in oncology is globally recognized as a revolutionary therapeutic modality with enormous potential.
Join a team that’s helping drive this new field.
People & Careers News
Dr Ian Nisbet, Chief Executive Officer, is attending both the RESI Investor Conference and BIO Partnering Dr Vera Evtimov, [...]
The Cartherics team recently gathered at the RACV Club in Healesville for a dynamic and inspiring offsite event focused on [...]
Cartherics’ Deputy Chair, Prof. Alan Trounson AO will be presenting at ISSCR 2025 on Friday 12th December, 2025 at 3.25pm [...]
Dr Ian Nisbet appointed as Chief Executive Officer Prof Alan Trounson AO will move into the role of Deputy [...]
Cartherics is pleased to announce that it will be presenting at the 8th Australian and New Zealand Society for Extracellular [...]
Today, Cartherics proudly hosted a Frocktober Afternoon Tea in support of ovarian cancer awareness and research. Frocktober is a meaningful [...]
Cartherics’ COO, Dr Ian Nisbet recently joined Xtalks’ Life Science Podcast to discuss Cartherics’ vision for next generation cell therapies. He discussed how Cartherics’ platform is building an effectively unlimited supply [...]
Cartherics is proud to share that our CEO, Professor Alan Trounson, was recently interviewed on 10 News+ by journalists Amelia [...]
Cartherics is pleased to announce that Mathew Tiedemann has officially completed his PhD, a major milestone in an already impressive [...]
In the competitive biotech landscape, groundbreaking science alone isn't enough. As highlighted in a recent article by Dynamic Business, Cartherics' [...]
